Disruption in immune system markers [pro- and anti-inflammatory substances (e.g., C-reactive protein, interleukin-6, adiponectin, or cell-mediated immunity)] contributes to increased risk of infections, as well as the development of autoimmune disorders or other chronic disorders, including those associated with pain (85). Here, IL6 is linked to infection.